Reddon H, Grant C, Nosova E, Fairbairn N, Barrios R, Justice A, Nolan S, Socías ME, Milloy MJ The Veterans Aging Cohort Study (VACS) Index predicts mortality in a community-recruited cohort of HIV-positive people who use illicit drugs Clin Infect Dis PubMed

Brar R, Grant C, DeBeck K, Milloy MJ, Fairbairn N, Wood E, Kerr T, Hayashi K Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada Am J Drug Alcohol Abuse PubMed

Bach P, Hayashi K, Milloy MJ, Nosova E, Kerr T, Wood E, Fairbairn N Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: a gender-based analysis Drug Alcohol Rev PubMed

Brar R, Fairbairn N, Sutherland C, Nolan S Use of a novel prescribing approach for the treatment of opioid use disorder: buprenorphine/naloxone micro-dosing - a case series Drug Alcohol Rev PubMed

Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A, Wood E, Fairbairn N Treatment of stimulant use disorder: a systematic review of reviews PLoS One PubMed

Ickowicz S, Dong H, Ti L, Nolan S, Fairbairn N, Barrios R, Milloy MJ Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017 AIDS Care PubMed

Fairgrieve C, Nosova E, Milloy MJ, Fairbairn N, DeBeck K, Ahamad K, Wood E, Kerr T, Hayashi K Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting Subst Abus PubMed

Socías ME, Wood E, Dong H, Brar R, Bach P, Murphy SM, Fairbairn N Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): protocol for a non-inferiority randomized clinical trial Contemp Clin Trials PubMed

Bach P, Garrod E, Robinson K, Fairbairn N An acute care contingency management program for the treatment of stimulant use disorder: a case report J Addict Med PubMed

Priest KC, Gorfinkel L, Klimas J, Jones AA, Fairbairn N, McCarty D Comparing Canadian and United States opioid agonist therapy policies Int J Drug Policy PubMed